CLINICAL_TRIALS
trial_result
· 2021-11-10
Clinical Trial Update: REduCing Immunogenicity to PegloticasE (RECIPE) Study [Phase 2]
Summary
Phase 2 clinical trial RECIPE studying reducing immunogenicity to PegloticasE for gout chronic has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Gout Chronic | Phase 2 | Status: COMPLETED | Results posted: 2021-11-10